Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Emergent BioSolutions Inc. | Financial_Report.xls |
| EX-32.2 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-31.1 - Emergent BioSolutions Inc. | exhibit31_1.htm |
| EX-31.2 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-32.1 - Emergent BioSolutions Inc. | exhibit32_1.htm |
| EX-10 - Emergent BioSolutions Inc. | exhibt10.htm |
| 10-Q - Emergent BioSolutions Inc. | form10q.htm |
EXHIBIT 12
|
Ratio of Earnings to Fixed Charges
|
||||||||||||||||||||||||
|
Period Ended
|
||||||||||||||||||||||||
|
|
September 30,
|
Year Ended December 31,
|
||||||||||||||||||||||
|
(in thousands)
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Pretax income from continuing operations (1)
|
$
|
8,754
|
$
|
37,446
|
$
|
38,849
|
$
|
77,880
|
$
|
46,110
|
$
|
32,737
|
||||||||||||
|
Fixed charges
|
||||||||||||||||||||||||
|
Interest expensed
|
5,804
|
2,177
|
1,719
|
1,778
|
1,797
|
3,032
|
||||||||||||||||||
|
Debt issuance cost
|
2,902
|
67
|
135
|
113
|
159
|
54
|
||||||||||||||||||
|
Total fixed charges (2)
|
8,706
|
2,244
|
1,854
|
1,891
|
1,956
|
3,086
|
||||||||||||||||||
|
Noncontrolling interest in pretax income (3)
|
-
|
5,381
|
6,906
|
4,514
|
4,599
|
724
|
||||||||||||||||||
|
Capitalized interest (4)
|
1,575
|
2,171
|
1,713
|
1,796
|
1,790
|
3,023
|
||||||||||||||||||
|
Earnings ((1) + (2) -(3) -(4))
|
15,885
|
32,138
|
32,084
|
73,461
|
41,677
|
32,076
|
||||||||||||||||||
|
Fixed charges
|
8,706
|
2,244
|
1,854
|
1,891
|
1,956
|
3,086
|
||||||||||||||||||
|
Ratio of earnings to fixed charges
|
1.8
|
14.3
|
17.3
|
38.8
|
21.3
|
10.4
|
||||||||||||||||||